DE69016129D1 - Vakzin gegen Escherichia coli. - Google Patents

Vakzin gegen Escherichia coli.

Info

Publication number
DE69016129D1
DE69016129D1 DE69016129T DE69016129T DE69016129D1 DE 69016129 D1 DE69016129 D1 DE 69016129D1 DE 69016129 T DE69016129 T DE 69016129T DE 69016129 T DE69016129 T DE 69016129T DE 69016129 D1 DE69016129 D1 DE 69016129D1
Authority
DE
Germany
Prior art keywords
escherichia coli
vaccine against
against escherichia
vaccine
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69016129T
Other languages
English (en)
Other versions
DE69016129T2 (de
Inventor
Den Bosch Johannes Francis Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69016129D1 publication Critical patent/DE69016129D1/de
Publication of DE69016129T2 publication Critical patent/DE69016129T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69016129T 1989-08-18 1990-07-23 Vakzin gegen Escherichia coli. Expired - Lifetime DE69016129T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (2)

Publication Number Publication Date
DE69016129D1 true DE69016129D1 (de) 1995-03-02
DE69016129T2 DE69016129T2 (de) 1995-05-24

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69016129T Expired - Lifetime DE69016129T2 (de) 1989-08-18 1990-07-23 Vakzin gegen Escherichia coli.

Country Status (16)

Country Link
US (1) US5750115A (de)
EP (1) EP0413378B1 (de)
JP (1) JP3031561B2 (de)
KR (1) KR0177510B1 (de)
CN (1) CN1062605C (de)
AU (1) AU635062B2 (de)
CA (1) CA2022420C (de)
DE (1) DE69016129T2 (de)
DK (1) DK0413378T3 (de)
ES (1) ES2070266T3 (de)
GR (1) GR3015782T3 (de)
HU (2) HU210965B (de)
IL (1) IL95175A (de)
NZ (1) NZ234933A (de)
TW (1) TW204353B (de)
ZA (1) ZA906100B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314224B1 (de) * 1987-10-26 1992-05-27 Akzo N.V. Impfstoff gegen E.Coli-Blutvergiftung bei Geflügel
EP1011440A4 (de) * 1997-05-16 2003-08-06 Medical Defense Tech Llc Impfstoff gegen den kern von lipopolysacchariden
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
BR9910438A (pt) * 1998-05-15 2001-01-02 Mkb Invest Ltd Partnership Composições e processos para imunização de aves domésticas
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
EP1934349A4 (de) * 2005-08-30 2009-05-27 Commw Scient Ind Res Org Bakterielle zuführung biologisch wirksamer polypeptide
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
JP6199557B2 (ja) 2009-10-12 2017-09-20 ニュー ヘルス サイエンシーズ、インク．Ｎｅｗ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 酸素及び二酸化炭素の減損能力をもつ血液保存袋システム及び減損装置
NZ599890A (en) 2009-10-12 2014-03-28 Univ Pittsburgh Oxygen depletion devices and methods for removing oxygen from red blood cells
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
EP4091645A1 (de) 2010-08-25 2022-11-23 Hemanext Inc. Verfahren zur erhöhung der qualität von erythrozyten und zur verlängerung ihrer lebensdauer während der lagerung
JP5859558B2 (ja) 2010-11-05 2016-02-10 ニュー・ヘルス・サイエンシーズ・インコーポレイテッドＮｅｗ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 赤血球の照射及び嫌気性保存
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
EP4074395B1 (de) 2011-08-10 2024-01-24 Hemanext Inc. Integrierte leukozyten-, sauerstoff- und/oder co2-abreicherung und filtervorrichtung zum trennen von plasma
WO2014134503A1 (en) 2013-02-28 2014-09-04 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
KR102701691B1 (ko) 2015-03-10 2024-08-30 헤마넥스트 인코포레이티드 산소 감소 1회용 키트, 장치 및 이의 사용 방법
CN107847395B (zh) 2015-04-23 2021-10-15 新健康科学股份有限公司 厌氧血液储存容器
BR122021024410B1 (pt) 2015-05-18 2022-05-03 Hemanext Inc Métodos para gerenciar um banco de sangue e para prover fornecimento de produtos de sangue total armazenados para medicina de transfusão
IL303240A (en) 2016-05-27 2023-07-01 Hemanext Inc Anaerobic blood storage and pathogen inactivation method
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.

Also Published As

Publication number Publication date
KR0177510B1 (ko) 1999-03-20
CA2022420A1 (en) 1991-02-19
ZA906100B (en) 1991-05-29
IL95175A (en) 1994-05-30
KR910004209A (ko) 1991-03-28
HU905053D0 (en) 1991-01-28
HU211827A9 (en) 1995-12-28
ES2070266T3 (es) 1995-06-01
HUT59612A (en) 1992-06-29
GR3015782T3 (en) 1995-07-31
CN1062605C (zh) 2001-02-28
AU6109990A (en) 1991-02-21
AU635062B2 (en) 1993-03-11
DE69016129T2 (de) 1995-05-24
EP0413378A1 (de) 1991-02-20
JP3031561B2 (ja) 2000-04-10
TW204353B (de) 1993-04-21
CN1049523A (zh) 1991-02-27
EP0413378B1 (de) 1995-01-18
DK0413378T3 (da) 1995-05-15
NZ234933A (en) 1992-06-25
JPH03184996A (ja) 1991-08-12
CA2022420C (en) 2000-03-28
HU210965B (en) 1995-09-28
US5750115A (en) 1998-05-12
IL95175A0 (en) 1991-06-10

Similar Documents

Publication Publication Date Title
DE69016129D1 (de) Vakzin gegen Escherichia coli.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI922252A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
FI906367A0 (fi) Terapeutiska nukleosider.
FI923273A0 (fi) Med dubbelminne foersett multiprocessorsystem.
FI913899A0 (fi) Terapeutiska aerosolblandningar.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
FI902502A0 (fi) Ampull.
DE69021383D1 (de) Medizinisches beatmungsgerät.
DE59007669D1 (de) Lithotriptor.
FI920152A0 (fi) Kirurgisk borrschablon.
FR2678381B1 (fr) Consistometre.
DE3882781D1 (de) Impfstoff gegen pasteurella.
FI904854A0 (fi) Terapeutiska nukleosider.
DE69200956D1 (de) Panzerung.
NO903978L (no) Pyridinyl-kinolonforbindelser, deres fremstilling og bruk.
DE69021761D1 (de) Impfstoff gegen Tinea.
FI922979A0 (fi) 2-piperidin-l-yl)etanolderivat, deras framstaellning och terapeutiska anvaendning.
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.
MX9200532A (es) Agente farmaceuticos.
FI925333A0 (fi) Foerbaettrad produktion av poly-beta-hydroxibutyrat i transformerad escherichia coli
DE59105322D1 (de) Stativ.
NL191819C (nl) Mantel met onttrek-vasthoudmechanisme.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL